An Overview of Marijuana Legalization: Initiatives for Law Research

Expungements weren’t as automatic as originally envisioned, with some cases stalled on technical issues. The law allows adults 21 and over to possess up to two ounces of flower, permits the home cultivation of up to six plants, and automatically wipes the records of those convicted of low-level cannabis offenses. Making matters more difficult, medical patients are not permitted to grow at home.

However — the study was limited by the timing between data collection and the addition of new states legalizing recreational cannabis.19 One study showed a statistically significant association between legalized recreational cannabis and greater likelihood of transitioning to using cannabis when compared with both nonlegalized states (odds ratio OR 2.18, 95% CI 1.37–3.45) and nonlegalized states combined with medical legalization states (OR 1.73, 95% CI 1.23–2.42). The debate about recreational cannabis legalization remains contentious both globally and within the United States.

In December 2002, a study by RAND investigating whether cannabis use results in the subsequent use of cocaine and heroin was published in the British Journal of Addiction. The study recommended Connecticut reduce cannabis possession of one ounce or less for adults age 21 and over to a civil fine. In 1997, the Connecticut Law Revision Commission examined states that had decriminalized cannabis and found decriminalizing small amounts of cannabis has no effect on subsequent use of alcohol or “harder” illicit drugs. However, multiple studies have found no evidence of a correlation between cannabis use and the subsequent use of other illicit drugs. It is hardly a revelation that people who use one of the least popular drugs are likely to use the more popular ones — not only marijuana, but also alcohol and tobacco cigarettes. Some of the main reasons for this substitute were ‘less withdrawal’, ‘fewer side-effects’ and ‘better symptom management’.

Understanding Marijuana Legalization in a Minute

Then what they use it for is really all over the place—maybe because it makes them feel good (or because it helps them deal with making informed cannabis product choices certain symptoms), diseases, and disorders. It’s not like a medication you get prescribed for a very narrow symptom or a specific disease. Some want marijuana to be regulated like alcohol.

They reported that over 41 percent of the people said that they prefer to use marijuana instead of alcohol. A 2020 study by researchers at UCLA and Yale found that cannabis legalization had led to large amounts of new tax revenue and very little black market cannabis sales in states where the market was well-regulated — but large black markets and lack of tax revenue in states like California with poor regulation. In 2006 (a study by the University of California), Los Angeles found California has saved $2.50 for every dollar invested into Proposition 36, which decriminalized cannabis and other drug possession charges by allowing outpatient treatment programs instead of incarceration. That same study also indicated that the mountainous regions in Appalachia — and the rural areas of the West Coast are ideal for growing cannabis.

REPORTS ON THE INDUSTRY

There is concern that recreational cannabis legalization could lead to an increase in cannabis use disorder. Notable increases were seen in alcohol use disorder (OR 2.7, 95% CI 1.9–3.8), nicotine dependence (OR 1.7, 95% CI 1.2–2.4), and other substance use disorders (OR 2.6, 95% CI 1.6–4.4). The strengths of these associations are unclear (and the causal link between cannabis use and these disorders has yet to be fully established), highlighting the need for more rigorous studies. Nearly half of regular users—defined as weekly or more frequent use35—experience withdrawal symptoms when cannabis is abruptly discontinued.28 These symptoms can include dysphoria, nausea, abdominal pain, tremors, sweating, fever, chills, and headaches.31,36,37 Whereas blood alcohol concentration can be used to determine acute alcohol intoxication, cannabis presents difficulties due to its high lipophilicity and pharmacokinetic properties.28 For instance, urine drug screens commonly used in emergency departments may report positive tetrahydrocannabinol results up to 30 days after consumption.29 Although negative effects on coordination and reflexes can be observed at the roadside, there is currently a lack of standardized measurement tools to accurately assess acute cannabis impairment. While cannabis use may influence driving abilities, the seemingly contradictory study findings suggest that the overall impact of cannabis legalization on traffic safety requires further investigation to clarify the association between patterns of cannabis use and traffic safety outcomes.

What won’t change with marijuana’s rescheduling?

Understanding the difference matters if you want to stay out of trouble. In this guide (we’re going to break it all down in plain language), so you know exactly what you can and can’t do, no matter where you are. Several studies have found no increase in teen use in states that have legalized cannabis for medical purposes.

Does this rescheduling legalize marijuana under federal law?

The new order clearly states that researchers studying sanctioned medical marijuana products will not be in violation of federal law. The reclassification (which follows a 2022 law that sought to reduce scientists’ administrative burdens), could further reduce red tape for researchers trying to study marijuana. When Congress finally takes a meaningful swing—be it SAFE Banking (FDCA reform), or full descheduling—operators who prepared today will capture tomorrow’s upside. Banking Marginally easier for national banks wary of “proceeds of criminal activity.” FinCEN guidance unchanged; SAFE Banking Act still needed. Unlike alcohol (THC can remain detectable in the body long after its impairing effects have worn off), making it challenging to establish clear legal standards for impaired driving.

U.S. Vape Market Report: Free Download

As a result, the limited mission and scope of NIDA led to the denial or alteration of many studies regarding the therapeutic effects of cannabis. To examine the effects of recreational cannabis legalization on rates of adverse cannabis-drug interactions, additional research is essential. Nonetheless, the unclear pathophysiology of cannabis use disorder is due to a lack of sufficient evidence supporting the idea that striatal dopamine receptors, which are associated with alcohol and opioid abuse disorders, also influence cannabis use disorder.37

This may affect research that contrasts states with legalized recreational cannabis to those without, as the rise in reported usage could distort the findings. The legalization of recreational cannabis might lead to an increase in self-reported cannabis use, driven by a perception of lower risk, biases toward social desirability, and reduced fear of legal repercussions. Acknowledging that most epidemiological research on substance use depends on self-reported information is crucial, as such data can lead to an underestimation of actual usage rates.14 Recall and social desirability biases make survey data susceptible, resulting in the underreporting or inaccurate representation of substance use.

In the American Journal of Psychiatry (a 12-year study conducted by the American Psychiatric Association on 214 boys aged 10 to 12 was published in December 2006), focusing on the gateway drug hypothesis. According to Paul Armentano, a policy analyst for NORML, the fact that THC was administered to the rats at just 28 days old makes it impossible to apply the findings of this study to humans. The rats were allowed to self-administer heroin by pressing a lever, and the findings indicated that those given THC consumed larger amounts of heroin. In the study (six out of twelve “teenage” rats received a small dose of THC), reportedly equivalent to one human joint, every three days. Additionally — the study revealed that both the average age of onset for cannabis use and the mean age of cannabis users were higher in Amsterdam compared to San Francisco. No evidence was found in the study to suggest that cannabis decriminalization leads to increased use of other illicit drugs.